Tobias Nicolaas Bonten

Tobias Nicolaas Bonten

Auto-generated profile, based on publicly available information

Tobias Nicolaas Bonten

Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, the Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2010 in Critical Care
Verified
Journal Article
Open access
PDF file
CNCees van Nieuwkoop
Cees van Nieuwkoop
TBTobias N Bonten
Tobias N Bonten
JWJan W Van'T Wout
Jan W Van'T Wout
EKEd J Kuijper
Ed J Kuijper
GGGeert H Groeneveld
Geert H Groeneveld
JDJaap T van Dissel
Jaap T van Dissel
Introduction: Guidelines recommend that two blood cultures be performed in patients with febrile urinary tract infection (UTI), to detect bacteremia and help diagnose urosepsis. The usefulness and cost-effectiveness of this practice have been criticized. This study aimed to evaluate clinical characteristics and the biomarker procalcitonin (PCT) as an aid in predicting bacteremia. Methods: A prospective observational multicenter cohort study included consecutive adults with febrile UTI in 35 primary care units and 8 emergency departments of 7 regional hospitals. Clinical and microbiological data were collected and PCT and time to positivity (TTP) of blood culture were measured. Results: Of 581 evaluable patients, 136 (23%) had bacteremia. The median age was 66 years (interquartile range 46 to 78 years) and 219 (38%) were male. We evaluated three different models: a clinical model including seven bed-side characteristics, the clinical model plus PCT, and a PCT only model. The diagnostic abilities of these models as reflected by area under the curve of the receiver operating characteristic were 0.71 (95% confidence interval (CI): 0.66 to 0.76), 0.79 (95% CI: 0.75 to 0.83) and 0.73 (95% CI: 0.68 to 0.77) respectively. Calculating corresponding sensitivity and specificity for the presence of bacteremia after each step of adding a significant predictor in the model yielded that the PCT > 0.25 μg/l only model had the best diagnostic performance (sensitivity 0.95; 95% CI: 0.89 to 0.98, specificity 0.50; 95% CI: 0.46 to 0.55). Using PCT as a single decision tool, this would result in 40% fewer blood cultures being taken, while still identifying 94 to 99% of patients with bacteremia. The TTP of E. coli positive blood cultures was linearly correlated with the PCT log value; the higher the PCT the shorter the TTP (R2 = 0.278, P = 0.007). Conclusions: PCT accurately predicts the presence of bacteremia and bacterial load in patients with febrile UTI. This may be a helpful biomarker to limit use of blood culture resources.

30 July 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
AWAnnah B. Wyss
Annah B. Wyss
TSTamar Sofer
Tamar Sofer
MLMi Kyeong Lee
Mi Kyeong Lee
NTNatalie Terzikhan
Natalie Terzikhan
JNJennifer N. Nguyen
Jennifer N. Nguyen
SLStephanie London
Stephanie London
Nearly 100 loci have been identified for pulmonary function, almost exclusively in studies of European ancestry populations. We extend previous research by meta-analyzing genome-wide association studies of 1000 Genomes imputed variants in relation to pulmonary function in a multiethnic population of 90,715 individuals of European (N = 60,552), African (N = 8429), Asian (N = 9959), and Hispanic/Latino (N = 11,775) ethnicities. We identify over 50 additional loci at genome-wide significance in ancestry-specific or multiethnic meta-analyses. Using recent fine-mapping methods incorporating functional annotation, gene expression, and differences in linkage disequilibrium between ethnicities, we further shed light on potential causal variants and genes at known and newly identified loci. Several of the novel genes encode proteins with predicted or established drug targets, including KCNK2 and CDK12. Our study highlights the utility of multiethnic and integrative genomics approaches to extend existing knowledge of the genetics of lung function and clinical relevance of implicated loci.

9 November 2016 in BMJ Open
Verified
Journal Article
Open access
PDF file
WSWouter A Spoelman
Wouter A Spoelman
TBTobias N Bonten
Tobias N Bonten
MWMargot W M de Waal
Margot W M de Waal
TDTon Drenthen
Ton Drenthen
ISIvo J M Smeele
Ivo J M Smeele
NCNiels H Chavannes
Niels H Chavannes
Objectives Healthcare costs and usage are rising. Evidence-based online health information may reduce healthcare usage, but the evidence is scarce. The objective of this study was to determine whether the release of a nationwide evidence-based health website was associated with a reduction in healthcare usage. Design Interrupted time series analysis of observational primary care data of healthcare use in the Netherlands from 2009 to 2014. Setting General community primary care. Population 912 000 patients who visited their general practitioners 18.1 million times during the study period. Intervention In March 2012, an evidence-based health information website was launched by the Dutch College of General Practitioners. It was easily accessible and understandable using plain language. At the end of the study period, the website had 2.9 million unique page views per month. Main outcomes measures Primary outcome was the change in consultation rate (consultations/1000 patients/month) before and after the release of the website. Additionally, a reference group was created by including consultations about topics not being viewed at the website. Subgroup analyses were performed for type of consultations, sex, age and socioeconomic status. Results After launch of the website, the trend in consultation rate decreased with 1.620 consultations/1000 patients/month (p<0.001). This corresponds to a 12% decline in consultations 2 years after launch of the website. The trend in consultation rate of the reference group showed no change. The subgroup analyses showed a specific decline for consultations by phone and were significant for all other subgroups, except for the youngest age group. Conclusions Healthcare usage decreased by 12% after providing high-quality evidence-based online health information. These findings show that e-Health can be effective to improve self-management and reduce healthcare usage in times of increasing healthcare costs.

1 April 2015 in Hypertension
Verified
Journal Article
Closed access
TBTobias N. Bonten
Tobias N. Bonten
JSJaapjan D. Snoep
Jaapjan D. Snoep
WAWillem J.J. Assendelft
Willem J.J. Assendelft
JZJaap Jan Zwaginga
Jaap Jan Zwaginga
JEJeroen Eikenboom
Jeroen Eikenboom
JBJohanna (Anske) Gerarda van der Bom
Johanna (Anske) Gerarda van der Bom
Aspirin is used for cardiovascular disease (CVD) prevention by millions of patients on a daily basis. Previous studies suggested that aspirin intake at bedtime reduces blood pressure compared with intake on awakening. This has never been studied in patients with CVD. Moreover, platelet reactivity and CVD incidence is highest during morning hours. Bedtime aspirin intake may attenuate morning platelet reactivity. This clinical trial examined the effect of bedtime aspirin intake compared with intake on awakening on 24-hour ambulatory blood pressure measurement and morning platelet reactivity in patients using aspirin for CVD prevention. In this randomized open-label crossover trial, 290 patients were randomized to take 100 mg aspirin on awakening or at bedtime during 2 periods of 3 months. At the end of each period, 24-hour blood pressure and morning platelet reactivity were measured. The primary analysis population comprised 263 (blood pressure) and 133 (platelet reactivity) patients. Aspirin intake at bedtime did not reduce blood pressure compared with intake on awakening (difference systolic/diastolic: −0.1 [95% confidence interval, −1.0, 0.9]/−0.6 [95% confidence interval, −1.2, 0.0] mm Hg). Platelet reactivity during morning hours was reduced with bedtime aspirin intake (difference: −22 aspirin reaction units [95% confidence interval, −35, −9]). The intake of low-dose aspirin at bedtime compared with intake on awakening did not reduce blood pressure of patients with CVD. However, bedtime aspirin reduced morning platelet reactivity. Future studies are needed to assess the effect of this promising simple intervention on the excess of cardiovascular events during the high risk morning hours.

2 September 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
ASAnna V Silven
Anna V Silven
APAnnelieke H J Petrus
Annelieke H J Petrus
MVMaría Villalobos-Quesada
María Villalobos-Quesada
EDEbru Dirikgil
Ebru Dirikgil
COCarlijn R Oerlemans
Carlijn R Oerlemans
YTY K Onno Teng
Y K Onno Teng
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 December 2010 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
CNCees van Nieuwkoop
Cees van Nieuwkoop
BHB. P. C. Hoppe
B. P. C. Hoppe
TBT. N. Bonten
T. N. Bonten
JWJ. W. Van’t Wout
J. W. Van’t Wout
NAN. J. M. Aarts
N. J. M. Aarts
JDJ. T. van Dissel
J. T. van Dissel
Background. Radiologic evaluation of adults with febrile urinary tract infection (UTI) is frequently performed to exclude urological disorders. This